What you say makes a lot of sense. Given Covid and its iterations looks like becomming the new normal, the world still has to get on with treating all the other human ailments. Diabetes in particular is a huge burden on all countries health systems. If these mainstream diseases are put back in the cue for too long, we will have another pandemic on our hands, so pathology labs need to probably expand to cope with this new demand. The new world order. For sure, PIQ need to secure commercial arrangements, the most likely contender is still Jansen. My own research suggests Jansen really need PIQ on board to justify their expensive drug Cannafloxin. Seems like a given to me, even though we wait in limbo. While your analysis sounds flawless, l really warm to the chartist guy with the reverse head and shoulders pattern who predicts this breaking out and climbing to $2.00. Who would know?
PIQ Price at posting:
$1.11 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)